Suppr超能文献

无肝脏疾病人群中安替比林代谢清除率与肝微粒体药物氧化酶活性之间的关系。

Relationship between metabolic clearance rate of antipyrine and hepatic microsomal drug-oxidizing enzyme activities in humans without liver disease.

作者信息

Vuitton D, Miguet J P, Camelot G, Delafin C, Joanne C, Bechtel P, Gillet M, Carayon P

出版信息

Gastroenterology. 1981 Jan;80(1):112-8.

PMID:7450397
Abstract

The aim of this study was to look for correlations between the metabolic clearance rate of antipyrine and (a) the concentration of cytochrome P-450, and (b) the NADPH cytochrome c reductase, aminopyrine demethylase, and aniline hydroxylase activities in the liver microsomes of 20 patients without liver diseases. The results confirmed interindividual differences in the values of in vivo and in vitro assessments of hepatic drug metabolism. No significant correlation appeared in this group of patients between the metabolic clearance rate of antipyrine and the microsomal amount of cytochrome P-450, whereas the metabolic clearance rate of antipyrine exhibited a significant relationship to the NADPH cytochrome c reductase (p < 0.05), aminopyrine demethylase (p < 0.05), and aniline hydroxylase (p < 0.02) activities. These results suggest that the metabolic clearance rate of antipyrine: (a) is not strictly related to the amount of cytochrome P-450 in hepatic microsomes; and (b) although significantly related to the activity of hepatic drug-metabolizing enzymes, does not have a predictive value to assess the enzyme equipment of liver microsomes in a given normal subject.

摘要

本研究的目的是探寻20名无肝脏疾病患者肝脏微粒体中安替比林的代谢清除率与(a)细胞色素P-450浓度,以及(b)NADPH细胞色素c还原酶、氨基比林脱甲基酶和苯胺羟化酶活性之间的相关性。结果证实了肝脏药物代谢的体内和体外评估值存在个体差异。在该组患者中,安替比林的代谢清除率与细胞色素P-450的微粒体量之间未出现显著相关性,而安替比林的代谢清除率与NADPH细胞色素c还原酶活性(p < 0.05)、氨基比林脱甲基酶活性(p < 0.05)和苯胺羟化酶活性(p < 0.02)呈现显著关系。这些结果表明,安替比林的代谢清除率:(a)与肝脏微粒体中细胞色素P-450的量并非严格相关;(b)虽然与肝脏药物代谢酶的活性显著相关,但对于评估特定正常受试者肝脏微粒体的酶装备并无预测价值。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验